• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Surgical

AmacaThera raises $10.3M in oversubscribed Series A

February 22, 2021 By Sean Whooley

AmacaThera announced today that it completed an oversubscribed $10.3 million Series A financing round. Lumira Ventures led the Series A funding, with existing investors Viva BioInnovator and Sprout BioVentures contributing as well. New investors BDC Capital Women in Technology Venture Fund, Inveready, MBX Capital, CR Capital Management, StandUp Ventures and MaRS IAF participated, too, according […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Hydrogels, Pain Management, Pharmaceuticals, Surgical Tagged With: AmacaThera

OncoSec announces positive results in metastatic melanoma case study

December 4, 2020 By Brian Buntz

Oncosec

The International Journal of Surgery Case Reports has published a case study on the use of the humanized antibody Keytruda (pembrolizumab) and tavokinogene telseplasmid (TAVO) from OncoSec (NSDQ:ONCS) for treating metastatic melanoma. The study involved a patient with stage IIB, pT3b melanoma who initially underwent tumor resection but experienced regional recurrence and later disease progression […]

Filed Under: Immunotherapy, Oncology, Surgical Tagged With: electroporation, Keytruda, melanoma, Oncosec, pembrolizumab, TAVO, tavokinogene telseplasmid

J&J’s Ethicon launches Vistaseal fibrin sealant

December 3, 2019 By Sean Whooley

Ethicon

Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon announced today that it launched its Vistaseal fibrin sealant for managing bleeding during surgery. The sealant system is indicated as an adjunct to hemostasis for mild to moderate bleeding in adults undergoing surgery when control of bleeding by standard techniques (suture, ligature, cautery) are ineffective or impractical. Vistaseal fibrin sealant consists […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Hematology, Surgical Tagged With: Ethicon, Grifols

J&J’s Ethicon wins clearance for devices to deliver Grifols surgical sealant

June 19, 2019 By Chris Newmarker

Johnson & Johnson Ethicon Grifols

Johnson & Johnson’s Ethicon has won FDA clearance for airless spray devices to deliver Grifols’ fibrin sealant to stop surgical bleeding, the companies announced today. The Vistaseal fibrin sealant will be the first product Grifols (NSDQ:GRFS) is introducing with Johnson & Johnson (NYSE:JNJ) and Ethicon as part of a global partnership. The 510(k) clearance covers three Vistaseal […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Regulatory/Compliance, Surgical Tagged With: Ethicon, Grifols, Johnson & Johnson

Researchers question use of antibiotic shunts in hydrocephalus patients

January 15, 2019 By Sarah Faulkner

Boston Children's Hospital - updated logo

Led by neurosurgeon Dr. Benjamin Warf, a team of researchers from Boston Children’s Hospital published a study this month questioning the benefits of using shunts impregnated with antibiotics to treat hydrocephalus. Hydrocephalus, which affects roughly 400,000 children each year, is characterized by fluid accumulation in the brain. Surgeons use shunts to drain the patient’s excess […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Neurological, Research & Development, Surgical Tagged With: Boston Children's Hospital

Intersect ENT touts pooled analysis of steroid-releasing sinus implants

November 19, 2018 By Sarah Faulkner

Intersect ENT updated

Intersect ENT (NSDQ:XENT) last week touted the publication of a pooled analysis of the company’s Propel Contour and Propel Mini steroid-eluting sinus implants. The company’s devices are designed to prop open the sinus ostia following endoscopic sinus surgery. As the implant dissolves, medicine is delivered directly to the sinus lining. The analysis, published in the International Forum […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Otolaryngology Ear, Nose & Throat, Pharmaceuticals, Surgical, Wall Street Beat Tagged With: Intersect ENT Inc.

EyePoint nabs CMS reimbursement for Dexycu cataract surgery drug

September 7, 2018 By Sarah Faulkner

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals (NSDQ:EYPT) said this week that the Centers for Medicare and Medicaid Services approved transitional pass-through status and reimbursement of its dexamethasone intraocular suspension, Dexycu. The FDA-approved product is designed to treat inflammation following cataract surgery using a single, intraocular dose of long-acting dexamethasone. “The receipt of pass-through status and the assignment of a […]

Filed Under: Featured, Optical/Ophthalmic, Pharmaceuticals, Surgical, Wall Street Beat Tagged With: eyepointpharmaceuticals

How Intuitive Surgical’s robotic systems are changing surgery

July 23, 2018 By Sarah Faulkner

DeviceTalks Boston promo

Robots are making their way into operating rooms around the world, acting as extensions of the surgeon. Intuitive Surgical, a mainstay in the robotic-assisted surgery field, has positioned its technologies as helping surgeons boost their performance and offer minimally-invasive options to patients. The company’s chief medical officer, Dr. Myriam Curet, shared her experience as a […]

Filed Under: Featured, Surgical, Technology Tagged With: intuitivesurgical

Medtech stories we missed this week: July 13, 2018

July 13, 2018 By Danielle Kirsh

missed-medtech-0713

From Angiodroid receiving CE Mark approval to Masimo launching its vital signs app, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Angiodroid wins CE Mark for Angiopulse IABP Angiodroid announced in a July 11 press releasethat it has received CE Mark approval for its AngioPulse intra-aortic balloon pump […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Hospital Care, Imaging, Optical/Ophthalmic, Orthopedics, Patient Monitoring, Regulatory/Compliance, Surgical

Medtech stories we missed this week: June 22, 2018

June 22, 2018 By Danielle Kirsh

missed-medtech-0622

From Accuray’s India approval to Masimo and PositiveID launching a Bluetooth-enabled thermometer, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. India approves Accuray’s Radixact X9 radiation therapy device Accuray announced in a June 21 press release that it has received an Atomic Energy Regulatory Board Type Approval in […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Imaging, Regulatory/Compliance, Surgical Tagged With: Accuray Inc., Arcuro Medical, BTG, Masimo, medtech, NuSight, PositiveID, Tenon Medical, TransMed7

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Interim pages omitted …
  • Page 7
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS